FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma

Autophagy. 2022 Jun;18(6):1416-1432. doi: 10.1080/15548627.2021.1987672. Epub 2021 Oct 31.

Abstract

Altered glutamine metabolism is an important aspect of cancer metabolic reprogramming. The GLS isoform GAC (glutaminase C), the rate-limiting enzyme in glutaminolysis, plays a vital role in cancer initiation and progression. Our previous studies demonstrated that phosphorylation of GAC was essential for its high enzymatic activity. However, the molecular mechanisms for GAC in maintaining its high enzymatic activity and protein stability still need to be further clarified. FAIM/FAIM1 (Fas apoptotic inhibitory molecule) is known as an important anti-apoptotic protein, but little is known about its function in tumorigenesis. Here, we found that knocking down FAIM induced macroautophagy/autophagy through suppressing the activation of the MTOR pathway in lung adenocarcinoma. Further studies demonstrated that FAIM could promote the tetramer formation of GAC through increasing PRKCE/PKCε-mediated phosphorylation. What's more, FAIM also stabilized GAC through sequestering GAC from degradation by protease ClpXP. These effects increased the production of α-ketoglutarate, leading to the activation of MTOR. Besides, FAIM also promoted the association of ULK1 and MTOR and this further suppressed autophagy induction. These findings discovered new functions of FAIM and elucidated an important molecular mechanism for GAC in maintaining its high enzymatic activity and protein stability.

Keywords: Autophagy; Fas apoptosis inhibitory molecule 1; glutaminase C; protein stability; tetramer formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung* / metabolism
  • Apoptosis Regulatory Proteins* / metabolism
  • Autophagy
  • Glutaminase / metabolism
  • Glutamine* / metabolism
  • Humans
  • Lung Neoplasms* / metabolism
  • TOR Serine-Threonine Kinases

Substances

  • Apoptosis Regulatory Proteins
  • FAIM protein, human
  • Glutamine
  • TOR Serine-Threonine Kinases
  • Glutaminase

Grants and funding

This work was supported by the National Natural Science Foundation of China [82030086]; National Natural Science Foundation of China [81902346]; National Natural Science Foundation of China [81874043]; Natural Science Foundation of Jiangxi Province [20192ACB20024]; Natural Science Foundation of Jiangxi Province [20192BAB215038]; the Training Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province [20204BCJ23023].